357 related articles for article (PubMed ID: 28579062)
1. Distribution of Nonperfusion Area on Ultra-widefield Fluorescein Angiography in Eyes With Diabetic Macular Edema: DAVE Study.
Fan W; Wang K; Ghasemi Falavarjani K; Sagong M; Uji A; Ip M; Wykoff CC; Brown DM; van Hemert J; Sadda SR
Am J Ophthalmol; 2017 Aug; 180():110-116. PubMed ID: 28579062
[TBL] [Abstract][Full Text] [Related]
2. SEVERITY OF DIABETIC MACULAR EDEMA CORRELATES WITH RETINAL VASCULAR BED AREA ON ULTRA-WIDE FIELD FLUORESCEIN ANGIOGRAPHY: DAVE Study.
Fan W; Uji A; Wang K; Falavarjani KG; Wykoff CC; Brown DM; Van Hemert J; Sagong M; Sadda SR; Ip M
Retina; 2020 Jun; 40(6):1029-1037. PubMed ID: 31356494
[TBL] [Abstract][Full Text] [Related]
3. Classification of Regions of Nonperfusion on Ultra-widefield Fluorescein Angiography in Patients with Diabetic Macular Edema.
Fang M; Fan W; Shi Y; Ip MS; Wykoff CC; Wang K; Falavarjani KG; Brown DM; van Hemert J; Sadda SR
Am J Ophthalmol; 2019 Oct; 206():74-81. PubMed ID: 30959003
[TBL] [Abstract][Full Text] [Related]
4. Relationship Between Retinal Fractal Dimension and Nonperfusion in Diabetic Retinopathy on Ultrawide-Field Fluorescein Angiography.
Fan W; Nittala MG; Fleming A; Robertson G; Uji A; Wykoff CC; Brown DM; van Hemert J; Ip M; Wang K; Falavarjani KG; Singer M; Sagong M; Sadda SR
Am J Ophthalmol; 2020 Jan; 209():99-106. PubMed ID: 31472160
[TBL] [Abstract][Full Text] [Related]
5. Targeted Retinal Photocoagulation for Diabetic Macular Edema with Peripheral Retinal Nonperfusion: Three-Year Randomized DAVE Trial.
Brown DM; Ou WC; Wong TP; Kim RY; Croft DE; Wykoff CC;
Ophthalmology; 2018 May; 125(5):683-690. PubMed ID: 29336896
[TBL] [Abstract][Full Text] [Related]
6. Changes in retinal ischaemic index correlate with recalcitrant macular oedema in retinal vein occlusion: WAVE study.
Kwon S; Wykoff CC; Brown DM; van Hemert J; Fan W; Sadda SR
Br J Ophthalmol; 2018 Aug; 102(8):1066-1071. PubMed ID: 29699979
[TBL] [Abstract][Full Text] [Related]
7. Baseline retinal vascular bed area on ultra-wide field fluorescein angiography correlates with the anatomical outcome of diabetic macular oedema to ranibizumab therapy: two-year analysis of the DAVE Study.
Fan W; Uji A; Wykoff CC; Brown DM; van Hemert J; Falavarjani KG; Wang K; Sadda SR; Ip M
Eye (Lond); 2023 Mar; 37(4):678-683. PubMed ID: 35332289
[TBL] [Abstract][Full Text] [Related]
8. Widefield OCT-Angiography and Fluorescein Angiography Assessments of Nonperfusion in Diabetic Retinopathy and Edema Treated with Anti-Vascular Endothelial Growth Factor.
Couturier A; Rey PA; Erginay A; Lavia C; Bonnin S; Dupas B; Gaudric A; Tadayoni R
Ophthalmology; 2019 Dec; 126(12):1685-1694. PubMed ID: 31383483
[TBL] [Abstract][Full Text] [Related]
9. Ultra-Wide-Field Fluorescein Angiography-Guided Normalization of Ischemic Index Calculation in Eyes With Retinal Vein Occlusion.
Wang K; Ghasemi Falavarjani K; Nittala MG; Sagong M; Wykoff CC; van Hemert J; Ip M; Sadda SR
Invest Ophthalmol Vis Sci; 2018 Jul; 59(8):3278-3285. PubMed ID: 29971447
[TBL] [Abstract][Full Text] [Related]
10. Distribution of Nonperfusion and Neovascularization on Ultrawide-Field Fluorescein Angiography in Proliferative Diabetic Retinopathy (RECOVERY Study): Report 1.
Fan W; Nittala MG; Velaga SB; Hirano T; Wykoff CC; Ip M; Lampen SIR; van Hemert J; Fleming A; Verhoek M; Sadda SR
Am J Ophthalmol; 2019 Oct; 206():154-160. PubMed ID: 31078541
[TBL] [Abstract][Full Text] [Related]
11. Ultra-Widefield Fluorescein Angiography as a Biomarker for Response to Switch in Therapy in Persistent DME.
Bahrami B; Hong T; Peto T; Chang A
Ophthalmic Surg Lasers Imaging Retina; 2019 Dec; 50(12):771-778. PubMed ID: 31877222
[TBL] [Abstract][Full Text] [Related]
12. Functional and morphological changes in diabetic macular edema over the course of anti-vascular endothelial growth factor treatment.
Reznicek L; Cserhati S; Seidensticker F; Liegl R; Kampik A; Ulbig M; Neubauer AS; Kernt M
Acta Ophthalmol; 2013 Nov; 91(7):e529-36. PubMed ID: 23647578
[TBL] [Abstract][Full Text] [Related]
13. Characterization of ischemic index using ultra-widefield fluorescein angiography in patients with focal and diffuse recalcitrant diabetic macular edema.
Patel RD; Messner LV; Teitelbaum B; Michel KA; Hariprasad SM
Am J Ophthalmol; 2013 Jun; 155(6):1038-1044.e2. PubMed ID: 23453693
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of Ranibizumab in Eyes with Diabetic Macular Edema and Macular Nonperfusion in RIDE and RISE.
Reddy RK; Pieramici DJ; Gune S; Ghanekar A; Lu N; Quezada-Ruiz C; Baumal CR
Ophthalmology; 2018 Oct; 125(10):1568-1574. PubMed ID: 29752001
[TBL] [Abstract][Full Text] [Related]
15. Long-term effect of intravitreal bevacizumab (avastin) in patients with chronic diffuse diabetic macular edema.
Kook D; Wolf A; Kreutzer T; Neubauer A; Strauss R; Ulbig M; Kampik A; Haritoglou C
Retina; 2008 Oct; 28(8):1053-60. PubMed ID: 18779710
[TBL] [Abstract][Full Text] [Related]
16. Diabetic Macular Edema Treatment with Bevacizumab Does Not Depend on the Retinal Nonperfusion Presence.
Sędziak-Marcinek B; Teper S; Chełmecka E; Wylęgała A; Marcinek M; Bas M; Wylęgała E
J Diabetes Res; 2021; 2021():6620122. PubMed ID: 33728349
[TBL] [Abstract][Full Text] [Related]
17. Intravitreal bevacizumab for diabetic macular edema associated with severe capillary loss: one-year results of a pilot study.
Bonini-Filho M; Costa RA; Calucci D; Jorge R; Melo LA; Scott IU
Am J Ophthalmol; 2009 Jun; 147(6):1022-30, 1030.e1-5. PubMed ID: 19327746
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of foveal capillary drop-out and previous panretinal photocoagulation for diabetic macular oedema treated with ranibizumab.
Ebneter A; Wolf S; Zinkernagel MS
Br J Ophthalmol; 2016 Mar; 100(3):365-70. PubMed ID: 26187951
[TBL] [Abstract][Full Text] [Related]
19. Distinguishing Diabetic Macular Edema From Capillary Nonperfusion Using Optical Coherence Tomography Angiography.
de Carlo TE; Chin AT; Joseph T; Baumal CR; Witkin AJ; Duker JS; Waheed NK
Ophthalmic Surg Lasers Imaging Retina; 2016 Feb; 47(2):108-14. PubMed ID: 26878442
[TBL] [Abstract][Full Text] [Related]
20. Persistent Macular Thickening After Ranibizumab Treatment for Diabetic Macular Edema With Vision Impairment.
Bressler SB; Ayala AR; Bressler NM; Melia M; Qin H; Ferris FL; Flaxel CJ; Friedman SM; Glassman AR; Jampol LM; Rauser ME;
JAMA Ophthalmol; 2016 Mar; 134(3):278-85. PubMed ID: 26746868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
